(1991) A 5-year study of cryosurgery in the treatment of liver tumours. Archives of Surgery; 126: 1520-1524 This report summarizes our 5-year experience with cryosurgery for in situ ablation of liver tumors. The liver was exposed with laparotomy, and the tumors were subjected to two freeze-thaw cycles using liquid nitrogen delivered by insulated probes; cryoablation was monitored with intra-operative ultrasonography. Tumor markers and computed tomography evaluated tumor response during long-term follow-up. From 1985 to 1990, 32 patients (19 men and 13 women) were entered into this study. The histologic characteristics of the tumors were as follows" colorectal, 24 patients; hepatoma, three patients; neuroendocrine, two patients; and others, three patients. After a follow-up period of 5 to 60 months (median follow-up, 24 months), nine patients (28%) remained disease free, 11 patients (34%) were alive with disease, and 12 patients (38%) died. The patterns of failure included liver and extrahepatic disease in 54% of cases, liver disease only in 32% of cases, and extrahepatic disease only in 14% of cases. In patients with "liver only" failure, recurrence at the treatment site occurred in three patients (9%). This study establishes the long-term effectiveness of cryosurgery in the treatment of primary and metastatic liver tumors.
Cryosurgery has been used successfully for many years for tumour destruction in surgical fields. Perhaps it has been used most successfully and enthusiastically for the treatment of skin cancers. Basal cell carcinomas and some epitheliomas can be treated with a reported cure rate of 97.6%. These results are comparable to surgical excision and radiotherapy1'2. There are two main advantages of cryodestruction over other treatments for skin lesions: frequently only one outpatient attendance is needed and healing is almost perfect, except around the eyes, with minimal scarring. Sometimes Cryosurgery is a simple technique and there are several liquid nitrogen cooled cryosurgical machines on the market. There has been some engineering development of the probes recently and some are now fine enough and sufficiently insulated to be inserted into tumours. Most evidence suggests that two freeze-thaw cycles using a liquid nitrogen cooled probe will provide total destruction of any cells. Since it is so straight forward a procedure it is surprising that it does not attract more attention from clinicians.
Unfortunately most enthusiasts who advocate using the technique fail to carry out randomised studies designed to compare prospectively the results of cryosurgery and more conventional treatments of the same tumour. This is the case in the management of liver tumours and this paper by Ravikumar and colleagues is another example. It set out to study the value of cryosurgery for treating patients with a mixed bag of primary and secondary liver tumours (mostly secondary) not suitable for surgical resection. The authors describe clearly how they use ultrasound guidance to watch in real time the growth of the ice ball through the malignant lesion. They and others 6'7 have shown previously that this is a very practical and effective technique for ensuring all the tumour is frozen. In this paper they show that they are able to totally destroy some malignant lesions in the liver by local freezing. However although the overall results of treatment in this group of patients, who were not amenable to surgery, were encouraging, there were no controls against which the effect of the cryosurgical treatment could be judged. By very nature of the fact that the patients treated were "inoperable" the tumours must have been quite advanced.
The subsequent discussion of this paper by others at the meeting to which it was presented centred on the treatment of these advanced and inoperable liver tumours. However in this situation the success or failure of local treatment is often determined by progression of untreated metastatic disease at other sites. Dr Gage says, "Findings of some reports have suggested that the survival of patients with metastatic carcinoma is extended by cryosurgical treatment. Whether or not this is true will require additional study''2.
Certainly it seems that cryodestruction is a valuable therapeutic modality for treating liver cancers. It is safe and in one study of 60 patients with primary liver cancer treated by cryosurgery there were no complications of bile leakage, bleeding, infection or operative death8.
I believe the next step now is to design a prospective study of the treatment of not inoperable lesions but small and operable tumours. It should compare surgical resection, cryotherapy and the other technique reported to destroy liver tumours, absolute alcohol injection9. To make such a study really meaningful it would be necessary, too, to include an untreated limb. However the ethics of this would need careful discussion. As a result of such a study we would really gain some idea of the
